XML 43 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividends declared and paid

Fiscal Year

    

2023

    

2022

Third quarter ended March 31,

$

0.120

$

0.100

Second quarter ended December 31,

0.120

0.075

First quarter ended September 30,

0.120

0.075

Schedule of share repurchases

The following table summarizes all treasury stock purchases during the nine months ended March 31, 2023 and 2022:

Nine Months Ended

March 31, 

    

2023

2022

Number of treasury shares acquired(1)

650,435

7,385

Average cost per share(1)

$

6.12

$

5.09

Total cost of treasury shares acquired

$

3,982,849

$

37,596

(1)For the nine months ended March 31, 2023, includes 633,789 shares repurchased under the Company’s share repurchase program for a weighted average price of $6.07 per share.

Schedule of Market-based Award Valuation Assumptions

For performance-based awards granted during the nine months ended March 31, 2023 and 2022, the assumptions used in the Monte Carlo simulation valuations were as follows:

Nine Months Ended

March 31, 

    

2023

    

2022

Weighted average fair value of performance-based awards granted

$

6.52

$

3.10

Risk-free interest rate

3.91% to 4.51%

0.53% to 0.60%

Expected term in years

2.36 to 2.78

2.64 to 2.79

Expected volatility

56.5% to 70.9%

64.7%

Dividend yield

6.1% to 7.8%

4.8% to 6.3%

Schedule of restricted stock unit transactions

Nine Months Ended

March 31, 

    

2023

    

2022

Weighted average fair value of performance-based awards granted

$

6.52

$

3.10

Risk-free interest rate

3.91% to 4.51%

0.53% to 0.60%

Expected term in years

2.36 to 2.78

2.64 to 2.79

Expected volatility

56.5% to 70.9%

64.7%

Dividend yield

6.1% to 7.8%

4.8% to 6.3%

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock unit transactions

The following table sets forth the restricted stock transactions for the nine months ended March 31, 2023:

Weighted

Weighted

Unamortized

Average

Number of

Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

    

Shares

    

Fair Value

    

(In thousands)

    

Period (Years)

Unvested at June 30, 2022

341,211

4.54

$

1,092

2.1

Time-vested shares granted

376,015

7.18

Performance-based shares granted

100,239

7.39

Vested

(133,515)

5.37

Forfeited

(25,620)

6.51

Unvested at March 31, 2023

658,330

$

6.24

$

3,279

2.5

Contingent restricted stock grants  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock unit transactions

Weighted

Unamortized

Average

Number of

Weighted Average

Compensation

Remaining

Restricted

Grant-Date

Expense

Amortization

 

    

Stock Units

    

Fair Value

    

(In thousands)

    

Period (Years)

Unvested at June 30, 2022

50,062

2.21

$

68

1.7

Performance-based awards granted

50,123

4.79

Vested

Forfeited

(3,787)

3.69

Expired

Unvested at March 31, 2023

96,398

$

3.49

$

227

2.1